These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 23780972)

  • 21. Cancer stem cells markers CD44, CD24 and ALDH1 in breast cancer special histological types.
    de Beça FF; Caetano P; Gerhard R; Alvarenga CA; Gomes M; Paredes J; Schmitt F
    J Clin Pathol; 2013 Mar; 66(3):187-91. PubMed ID: 23112116
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epithelial-mesenchymal transition and cancer stem cells in endometrial cancer.
    Supernat A; Lapinska-Szumczyk S; Majewska H; Gulczynski J; Biernat W; Wydra D; Zaczek AJ
    Anticancer Res; 2013 Dec; 33(12):5461-9. PubMed ID: 24324082
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An IL6-STAT3 loop mediates resistance to PI3K inhibitors by inducing epithelial-mesenchymal transition and cancer stem cell expansion in human breast cancer cells.
    Yang L; Han S; Sun Y
    Biochem Biophys Res Commun; 2014 Oct; 453(3):582-7. PubMed ID: 25285632
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Breast cancer stem cells: obstacles to therapy.
    Smalley M; Piggott L; Clarkson R
    Cancer Lett; 2013 Sep; 338(1):57-62. PubMed ID: 22554712
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fresh surgical specimens yield breast stem/progenitor cells and reveal their oncogenic abnormalities.
    Pommier SJ; Hernandez A; Han E; Massimino K; Muller P; Diggs B; Chamberlain E; Murphy J; Hansen J; Naik A; Vetto J; Pommier RF
    Ann Surg Oncol; 2012 Feb; 19(2):527-35. PubMed ID: 21748247
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Breast cancer stem cells and epithelial mesenchymal plasticity - Implications for chemoresistance.
    Pinto CA; Widodo E; Waltham M; Thompson EW
    Cancer Lett; 2013 Nov; 341(1):56-62. PubMed ID: 23830804
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Changes in Tumor Stem Cell Markers and Epithelial-Mesenchymal Transition Markers in Nonluminal Breast Cancer after Neoadjuvant Chemotherapy and Their Correlation with Contrast-Enhanced Ultrasound.
    Leng X; Huang G; Zhang L; Ding J; Ma F
    Biomed Res Int; 2020; 2020():3869538. PubMed ID: 33282946
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MicroRNAs regulate both epithelial-to-mesenchymal transition and cancer stem cells.
    Ceppi P; Peter ME
    Oncogene; 2014 Jan; 33(3):269-78. PubMed ID: 23455327
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [New aspects of the pathogenesis and classification of basal-like breast carcinoma].
    Gorelik MZ; Andreeva IuIu; Zavalishina LÉ
    Arkh Patol; 2013; 75(4):48-53. PubMed ID: 24313193
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epithelial-to-mesenchymal transition and cancer stem cells contribute to breast cancer heterogeneity.
    Hong D; Fritz AJ; Zaidi SK; van Wijnen AJ; Nickerson JA; Imbalzano AN; Lian JB; Stein JL; Stein GS
    J Cell Physiol; 2018 Dec; 233(12):9136-9144. PubMed ID: 29968906
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Meta-Analysis of Tumor Stem-Like Breast Cancer Cells Using Gene Set and Network Analysis.
    Lee WJ; Kim SC; Yoon JH; Yoon SJ; Lim J; Kim YS; Kwon SW; Park JH
    PLoS One; 2016; 11(2):e0148818. PubMed ID: 26870956
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tissue-based identification of stem cells and epithelial-to-mesenchymal transition in breast cancer.
    Anwar TE; Kleer CG
    Hum Pathol; 2013 Aug; 44(8):1457-64. PubMed ID: 23574782
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mathematical modelling of phenotypic plasticity and conversion to a stem-cell state under hypoxia.
    Dhawan A; Madani Tonekaboni SA; Taube JH; Hu S; Sphyris N; Mani SA; Kohandel M
    Sci Rep; 2016 Feb; 6():18074. PubMed ID: 26838463
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cancer stem cells, EMT, and seeding: a rose is a rose is a rose?
    Norton L
    Oncology (Williston Park); 2011 Jan; 25(1):30, 32. PubMed ID: 21361240
    [No Abstract]   [Full Text] [Related]  

  • 35. Epithelial Plasticity During Human Breast Morphogenesis and Cancer Progression.
    Ingthorsson S; Briem E; Bergthorsson JT; Gudjonsson T
    J Mammary Gland Biol Neoplasia; 2016 Dec; 21(3-4):139-148. PubMed ID: 27815674
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Breast cancer stem cell research utilizing clinical specimens].
    Mukohyama J; Shimono Y
    Nihon Rinsho; 2015 May; 73(5):831-5. PubMed ID: 25985639
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evolving views of breast cancer stem cells and their differentiation States.
    Condiotti R; Guo W; Ben-Porath I
    Crit Rev Oncog; 2014; 19(5):337-48. PubMed ID: 25404149
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cancer stem-like cells and epithelial-mesenchymal transition-utility of biomarkers in diagnostic pathology.
    Lloyd RV
    Hum Pathol; 2013 Aug; 44(8):1455-6. PubMed ID: 23859632
    [No Abstract]   [Full Text] [Related]  

  • 39. Issues of banking breast cancer cells to generate mammospheres.
    Veneziani BM; De Placido S
    Cell Tissue Bank; 2013 Jun; 14(2):153-8. PubMed ID: 22669494
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Recent advances on study of human breast stem cells].
    Chen DB; Shen DH; Kan X
    Zhonghua Bing Li Xue Za Zhi; 2007 Jun; 36(6):423-5. PubMed ID: 17822633
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.